Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Retz

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Der Urologe. Ausg. A|September 1, 2011
[Interdisciplinary Working Group Bladder Cancer (IABC) in the German Cancer Society newly founded]M Retz
Der Urologe. Ausg. A|June 15, 2018
[Bladder cancer : Current diagnosis and treatment modalities]M Retz, A Karl
Der Urologe. Ausg. A|May 11, 2018
[Supportive therapy, best supportive care, and palliative medicine]M Retz, H J Bardenheuer
Aktuelle Urologie|February 8, 2019
H Rexer, M Retz, C Waller
Der Urologe. Ausg. A|March 28, 2014
[Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow]R Nawroth, D Weckermann, M Retz
World Journal of Urology|May 26, 2001
The role of adjuvant chemotherapy for locally advanced bladder cancerJ Lehmann, M Retz, M Stöckle
Aktuelle Urologie|February 1, 2021
H Rexer, M Retz, M Kramer
Der Urologe. Ausg. A|March 3, 2017
[Side effects of chemotherapy]K Hauner, P Maisch, M Retz
Der Urologe. Ausg. A|April 12, 2018
[Advanced bladder cancer : From chemo- to immunotherapy]T Horn, S Krege, M Retz
Der Urologe. Ausg. A|October 8, 2016
[Adjuvant study of high-risk muscle invasive urothelial carcinoma : Open-label, multicenter, randomized phase III study with atezolizumab (anti-PD-L1 antibody) as adjuvant therapy compared with observation in patients with high-risk muscle invasive urothelial carcinoma after surgical resection (IMvigor010)- study AB 53/15 of the AUO]H Rexer, M Retz, P Albers
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Der Urologe. Ausg. A|September 1, 2011
[Interdisciplinary Working Group Bladder Cancer (IABC) in the German Cancer Society newly founded]M Retz
Der Urologe. Ausg. A|June 15, 2018
[Bladder cancer : Current diagnosis and treatment modalities]M Retz, A Karl
Der Urologe. Ausg. A|May 11, 2018
[Supportive therapy, best supportive care, and palliative medicine]M Retz, H J Bardenheuer
Aktuelle Urologie|February 8, 2019
H Rexer, M Retz, C Waller
Der Urologe. Ausg. A|March 28, 2014
[Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow]R Nawroth, D Weckermann, M Retz
World Journal of Urology|May 26, 2001
The role of adjuvant chemotherapy for locally advanced bladder cancerJ Lehmann, M Retz, M Stöckle
Aktuelle Urologie|February 1, 2021
H Rexer, M Retz, M Kramer
Der Urologe. Ausg. A|March 3, 2017
[Side effects of chemotherapy]K Hauner, P Maisch, M Retz
Der Urologe. Ausg. A|April 12, 2018
[Advanced bladder cancer : From chemo- to immunotherapy]T Horn, S Krege, M Retz
Der Urologe. Ausg. A|October 8, 2016
[Adjuvant study of high-risk muscle invasive urothelial carcinoma : Open-label, multicenter, randomized phase III study with atezolizumab (anti-PD-L1 antibody) as adjuvant therapy compared with observation in patients with high-risk muscle invasive urothelial carcinoma after surgical resection (IMvigor010)- study AB 53/15 of the AUO]H Rexer, M Retz, P Albers
Pageof 9